Hua Z, Gong B, Li Z
Mol Neurobiol. 2025; .
PMID: 39979690
DOI: 10.1007/s12035-025-04759-y.
Wang J, Zhang H, Yan Z, Cao Z, Shao J, Zou L
Discov Oncol. 2024; 15(1):456.
PMID: 39292372
PMC: 11410741.
DOI: 10.1007/s12672-024-01318-0.
Pearson H, Bell C, Cox K, Kayum C, Knox L, Gibson F
Res Involv Engagem. 2024; 10(1):87.
PMID: 39123249
PMC: 11316368.
DOI: 10.1186/s40900-024-00620-z.
Hua Z, Chen B, Gong B, Lin M, Ma Y, Li Z
CNS Neurosci Ther. 2024; 30(3):e14664.
PMID: 38516781
PMC: 10958400.
DOI: 10.1111/cns.14664.
Boltman T, Meyer M, Ekpo O
Cancers (Basel). 2023; 15(13).
PMID: 37444498
PMC: 10341066.
DOI: 10.3390/cancers15133388.
Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
Chen J, Sun M, Chen C, Kang M, Qian B, Sun J
Front Immunol. 2023; 14:1135617.
PMID: 37081871
PMC: 10111050.
DOI: 10.3389/fimmu.2023.1135617.
BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis.
Jin L, Mi T, Wu X, Wang Z, Zhang Z, Liu J
Cancers (Basel). 2023; 15(7).
PMID: 37046682
PMC: 10093276.
DOI: 10.3390/cancers15072023.
SOX4 Mediates ATRA-Induced Differentiation in Neuroblastoma Cells.
Zhang D, Gong B, Zhao Q, Li Z, Tan X, Hua Z
Cancers (Basel). 2022; 14(22).
PMID: 36428735
PMC: 9688885.
DOI: 10.3390/cancers14225642.
Antitumor effect of -derived outer membrane vesicles on neuroblastoma and .
Jin L, Zhang Z, Tan X, Wang Z, Tang B, Wang Z
Acta Biochim Biophys Sin (Shanghai). 2022; 54(9):1301-1313.
PMID: 36148954
PMC: 9827812.
DOI: 10.3724/abbs.2022127.
METTL1 promotes neuroblastoma development through mG tRNA modification and selective oncogenic gene translation.
Huang Y, Ma J, Yang C, Wei P, Yang M, Han H
Biomark Res. 2022; 10(1):68.
PMID: 36071474
PMC: 9454133.
DOI: 10.1186/s40364-022-00414-z.
Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling.
Lebedev T, Buzdin A, Khabusheva E, Spirin P, Suntsova M, Sorokin M
Int J Mol Sci. 2022; 23(14).
PMID: 35887076
PMC: 9324519.
DOI: 10.3390/ijms23147724.
Anticancer potential of nitric oxide (NO) in neuroblastoma treatment.
Gordon J, Hinsen K, Reynolds M, Smith T, Tucker H, Brown M
RSC Adv. 2022; 11(16):9112-9120.
PMID: 35423416
PMC: 8695301.
DOI: 10.1039/d1ra00275a.
LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex.
Wang J, Wang Z, Lin W, Han Q, Yan H, Yao W
Mol Ther Oncolytics. 2022; 24:834-848.
PMID: 35317520
PMC: 8917274.
DOI: 10.1016/j.omto.2022.02.007.
Prognostic impact of tumor size on patients with neuroblastoma in a SEER-based study.
Wang J, Cao Z, Wang C, Zhang H, Fan F, Zhang J
Cancer Med. 2022; 11(14):2779-2789.
PMID: 35315591
PMC: 9302263.
DOI: 10.1002/cam4.4653.
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes.
Lebedev T, Vagapova E, Spirin P, Rubtsov P, Astashkova O, Mikheeva A
Oncogene. 2021; 40(44):6258-6272.
PMID: 34556815
PMC: 8566230.
DOI: 10.1038/s41388-021-02018-7.
Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways.
Chen Z, Gao J, Sun J, Wu Z, Wang B
Med Sci Monit. 2021; 27:e928813.
PMID: 33619241
PMC: 7911850.
DOI: 10.12659/MSM.928813.
Assessment of Tissue Distribution and Metabolism of MP1, a Novel Pyrrolomycin, in Mice Using a Validated LC-MS/MS Method.
Aldhafiri W, Chhonker Y, Zhang Y, Coutler D, McGuire T, Li R
Molecules. 2020; 25(24).
PMID: 33322110
PMC: 7764159.
DOI: 10.3390/molecules25245898.
Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F
Med Res Rev. 2020; 41(2):961-1021.
PMID: 33155698
PMC: 7906923.
DOI: 10.1002/med.21750.
Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors.
Tao T, Shi H, Wang M, Perez-Atayde A, London W, Gutierrez A
J Exp Med. 2020; 217(10).
PMID: 32728700
PMC: 7537400.
DOI: 10.1084/jem.20191871.
Nitric Oxide as a Potential Adjuvant Therapeutic for Neuroblastoma: Effects of NO on Murine N2a Cells.
Gordon J, Reynolds M, Brown M
Vet Sci. 2020; 7(2).
PMID: 32340209
PMC: 7355501.
DOI: 10.3390/vetsci7020051.
